cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Conditions
Brain Cancer · Breast Cancer · Bladder Cancer · Cervical Cancer · Colorectal Cancer · Endometrial Cancer · Esophageal Cancer · Stomach Cancer · Head and Neck Cancer · Hepatobiliary Cancer · Leukemia · Lung Cancer · Lymphoma · Multiple Myeloma · Ovarian Cancer · Pancreatic Cancer · Prostate Cancer · Renal Cancer · Sarcoma · Thyroid Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
City of Hope, Duarte, California, United States
Contact: Principal Investigator (Gregory Idos, MD)Miami Cancer Institute, Miami, Florida, United States
Contact: Principal Investigator (Manmeet Ahluwalia, MD)North Georgia Health System, Gainesville, Georgia, United States
Contact: Principal Investigator (Charles Nash, MD)Baptist Floyd, New Albany, Indiana, United States
Contact: Principal Investigator (Amitoj Gill, MD)Baptist Corbin, Corbin, Kentucky, United States
Contact: Principal Investigator (Abigail Byrnes, MD)Baptist Hardin, Elizabethtown, Kentucky, United States
Contact: Principal Investigator (Christopher Burkeen, MD)Baptist Lexington, Lexington, Kentucky, United States
Contact: Principal Investigator (Arvinda Padmanabhan, MD)Baptist Paducah, Paducah, Kentucky, United States
Allina Health Cancer Institute, Minneapolis, Minnesota, United States
Contact: Principal Investigator (Joleen Hubbard, MD)Mayo Clinic, Rochester, Minnesota, United States
Contact: Principal Investigator (Lisa A Boardman, MD)Cleveland Clinic, Cleveland, Ohio, United States
Contact: Principal Investigator (Peter Mazzone, MD, MPH)Oregon Health Sciences University, Portland, Oregon, United States
Contact: Principal Investigator (Nima Nabavizadeh, MD)Medical University of South Carolina, Charleston, South Carolina, United States
Contact: Principal Investigator (Gerard Silvestri, MD)McLeod Health, Florence, South Carolina, United States
Contact: Principal Investigator (Virginia Clyburn-Ipock, MD)Baptist (BHMCC), Memphis, Tennessee, United States
Contact: Principal Investigator (Philip Lammers, MD)Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
Contact: Principal Investigator (Brian Rini, MD)Elligo Health Research, Inc., Austin, Texas, United States
Contact: Principal Investigator (Faith Holmes, MD)
Study leads
Brian Rini, MD
Principal Investigator
Vanderbilt-Ingram Cancer Center